Skip to main content
Elsevier
View Cart
My account

Books in Pharmaceutical sciences

Elsevier's Pharmaceutical Sciences collection helps pharmaceutical scientists striving to optimize drug design and improve healthcare outcomes by offering comprehensive coverage of every aspect of drug development, integrating disciplines like organic chemistry, biology, and biotechnology. Focused on safety, efficacy, and formulation design, it includes specialized fields such as Clinical Pharmacology and Translational Research, providing valuable insights into the latest advancements in drug discovery.

BooksJournals

    • Nanotechnology in Cosmeceuticals

      • 1st Edition
      • November 1, 2025
      • Chin Wei Lai + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 0 1 8 4 1
      • eBook
        9 7 8 0 4 4 3 3 0 1 8 5 8
      Nanotechnology in Cosmeceuticals: Advances, Challenges and Future Perspectives explores the fundamental principles of nanotechnology in cosmetics required to understand chemistry related formulation and the dermatological effects of these products. This book by provides an in-depth analysis of nanotechnology in cosmeceuticals, covering pharmaceutical, chemical, and toxicological aspects. The contents of this book are divided in seven parts. The first lays the foundations of cosmetics, and nanotechnology applications. The second part focuses no nano-metaloxides, including titanium, zinc, gold, silver and others. The third part covers carbon-based products in cosmeceuticals with chapters on graphene, nano-hydroxyapatite, and general carbon-based products. The next part focuses on nano-organics, nanocellulose and biodegradable materials. Part five is dedicated to formulations of liposomes, lipids in drug delivery. Part six covers recent trends, advances, applications and progress of nanotechnology and nano products in cosmeceuticals. The final part focuses on safety and toxicity aspects of nano-cosmeceuticals. Nanotechnology in Cosmeceuticals: Advances, Challenges and Future Perspectives is an ideal reference for pharmacologists, cosmetic scientists, and chemists in academic research and corporate settings looking into leveraging nanoscience to improve the performance of cosmetics. Dermatologists and food scientists may also benefit from the foundational content present in the first part of the book.

    • Harnessing Endogenous Mechanisms for Targeted Drug Delivery

      • 1st Edition
      • December 1, 2025
      • Anisha A. D’Souza + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 7 4 2 9 9
      • eBook
        9 7 8 0 4 4 3 2 7 4 3 0 5
      Harnessing Endogenous Mechanisms for Targeted Drug Delivery explores the cutting-edge advancements in the world of targeted drug delivery leveraging human biological mechanisms. This essential guide addresses the urgent need to enhance the efficiency of drug delivery and foster safe and effective therapies, particularly for biological agents like proteins, peptides, and nucleic acid molecules. The book offers a comprehensive exploration of tissue- and cell-specific delivery methods, emphasizing endogenous or biological techniques that can be utilized to improve drug delivery. It identifies the challenges associated with delivering complex molecules and accessing hard-to-reach sites, and provides practical solutions through endogenous strategies. Topics such as exploiting disease-specific stimuli to enhance delivery efficiency, the role of plasma proteins in drug delivery, and the utilization of extracellular vesicles to boost delivery efficiency are presented. Harnessing Endogenous Mechanisms for Targeted Drug Delivery emphasizes the clinical and commercial translation of these techniques, making this book an ideal resource for researchers, clinicians, and anyone interested in the future of drug delivery.

    • Basic Principles of Drug Discovery and Development

      • 3rd Edition
      • December 19, 2025
      • Benjamin E. Blass
      • English
      Basic Principles of Drug Discovery and Development, Third Edition presents a unique overview of the drug discovery and development program not available elsewhere. Each chapter provides sufficient technical details on the topics covered so that non-experts will have the tools and information necessary to interact and exchange information with colleagues across the entire spectrum of the drug discovery and development process. The drug discovery and development process involves individuals and teams with a wide array of expertise ranging from basic sciences (medicinal chemistry, biology) to applied science (pharmacology, pharmacokinetics, clinical sciences) to business driven fields (regulatory affairs, intellectual property experts, marketing specialists).The success or failure of a program focused on bringing a new medication to market often depends on clear communication between individuals and teams with vastly different expertise. As a result, it is critical that experts in one aspect of drug discovery and development (e.g., medicinal chemists) have a working understanding of the wide range of disciplines that take part in the overall process.

    • Ophthalmic Drug Delivery

      • 1st Edition
      • September 25, 2025
      • Neelesh Kumar Mehra
      • English
      • Paperback
        9 7 8 0 4 4 3 3 3 7 8 1 9
      • eBook
        9 7 8 0 4 4 3 3 3 7 8 2 6
      Ophthalmic Drug Delivery: Advancement, Industrialization Prospect and Applications delves into the complexities and potential of scaling up and commercializing pharmaceutical innovations within ophthalmology. This book serves as a complete guide through research findings, industry insights, and regulatory guidelines, offering a thorough roadmap for the future of drug delivery systems targeting the eye. The importance of understanding the eye's physiology and anatomy is emphasized, laying the foundational knowledge necessary for developing effective treatments. The book continues by exploring various aspects such as novel formulations, fixed-dose combinations, and microbiological considerations.It also discusses cutting-edge research in reverse engineering approaches, the significance of Quality by Design (QbD), and the treatment of eye-related diseases like glaucoma, age-related macular degeneration, uveal melanoma, cataracts, and fungal keratitis. Corporate researchers will find the manufacturing insights particularly beneficial, making this an essential resource for professionals in the field of ophthalmic drug delivery.

    • Inorganic Biomaterials for Drug Delivery

      • 1st Edition
      • October 1, 2025
      • Amit Kumar Nayak + 2 more
      • English
      • Paperback
        9 7 8 0 3 2 3 9 5 3 6 6 5
      • eBook
        9 7 8 0 3 2 3 9 5 8 4 5 5
      Inorganic Biomaterials for Drug Delivery covers a wide range of inorganic biomaterial types and their properties, from traditional materials like ceramics, metallics, and bioglasses to novel composites and nano-engineered inorganic biomaterials. Biocompatibility, toxicity, and regulatory considerations are also thoroughly discussed, ensuring the reader is fully equipped for efficient biomaterials selection and utilization in drug delivery applications. This is a must-have reference for those working in the fields of materials science, biomedical engineering, pharmaceutical science, pharmacology, chemical engineering, and clinical science.

    • Biopharmaceutical Ecosystems

      • 1st Edition
      • October 1, 2025
      • David R. Williams
      • English
      • Paperback
        9 7 8 0 1 2 8 2 0 5 9 7 6
      • eBook
        9 7 8 0 1 2 8 2 0 6 2 2 5
      The ecosystem perspective on organizations and economic settings is relatively new. It expands on work that looks at bio-clusters, concentrating on the relationship between human and financial capital. The perspective takes an expansive view of biopharmaceuticals in relation to stakeholders and the social, political, and economic landscape, including other life science companies, academia, non-profits, government entities, and health systems. The biotechnology and pharmaceutical industries have been merging for some time, with biotechnology often portrayed as a disruptive innovation to the pharmaceutical industry. A fuller description of this activity put into the greater context of the ecosystem perspective is warranted.Biopharmac... Ecosystems: A Comparative Study of U.S. and European Systems puts forward a picture of biopharmaceutical ecosystems in the USA and Europe. It examines and expands current thinking on the development of the ecosystem perspective on biopharmaceuticals. The title considers multiple locations, with countries in the top 15 of biopharmaceutical exporters selected. It pays particular attention to shifts in the political and economic landscape, and how such changes affect ecosystems. The underlying aim of biopharmaceutical ecosystems is to further the development of new drugs, reduce time to market, and lower costs. In explaining ecosystems, the book applies a quadruple helix model - academia; consumer/society; government; and industry - to each region and country in light of this triple aim.

    • Sterility, Sterilisation and Sterility Assurance for Pharmaceuticals

      • 2nd Edition
      • August 12, 2025
      • Tim Sandle
      • English
      • Hardback
        9 7 8 0 4 4 3 3 6 4 3 6 5
      • eBook
        9 7 8 0 4 4 3 3 6 4 3 7 2
      Sterility, Sterilisation and Sterility Assurance for Pharmaceuticals: Technology, Validation and Current Regulations, Second Edition is an in-depth guide to the world of pharmaceutical sterilization. This new edition has been updated to reflect the latest standards and regulations, ensuring alignment with current practices. It explores emerging methods and techniques, complemented by new case studies that provide practical examples. Readers will gain comprehensive knowledge about sterilization’s critical role in healthcare and pharmaceutical manufacturing, highlighting the importance of controlling microbial challenges to ensure product safety and patient well-being.The book discusses sterility, sterilization methods such as gamma radiation, e-beam, dry heat, steam, gas, vapor, filtration, and new techniques like X-ray sterilization, liquid-phase sterilization, ultraviolet light, supercritical gases, and sterilization assurance governance. It covers biopharmaceutical manufacturing processes, including aseptic filling, container and packaging design, and cleanroom environments. This edition is essential for professionals in pharmaceuticals, healthcare, and medical device manufacturing, providing the knowledge needed to comply with current standards and regulations.

    • The Organic Chemistry of Drug Design and Drug Action

      • 4th Edition
      • December 19, 2025
      • Richard B. Silverman + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 5 8 6 2 9
      • eBook
        9 7 8 0 4 4 3 1 5 8 6 3 6
      The Organic Chemistry of Drug Design and Drug Action, Fourth Edition presents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action. The book's coverage allows readers to extrapolate core principles and mechanisms to many related classes of drug molecules. It reflects the significant changes in the process of drug design over the last decade and preserves the successful approach of the previous editions while also including significant changes in format and coverage.It is designed for undergraduate and graduate students in chemistry who are studying medicinal chemistry or pharmaceutical chemistry. Users, including research chemists and biochemists working in pharmaceutical and biotechnology industries will find this update to be useful in their daily work.

    • Fundamentals and Design of Drug Delivery Systems

      • 1st Edition
      • September 1, 2025
      • Wujie Zhang
      • English
      • Paperback
        9 7 8 0 4 4 3 2 3 5 2 1 4
      • eBook
        9 7 8 0 4 4 3 2 3 5 2 0 7
      Fundamentals and Design of Drug Delivery Systems: A Textbook with Lab Activities is an essential resource for pharmaceutical sciences and engineering students. Covering all key concepts related to drug delivery courses, it introduces basic pharmacology, barriers to drug delivery, drug targeting, and novel drug delivery systems. Design considerations and approaches are thoroughly illustrated. The textbook reflects nanotechnology in various chapters and includes practical lab activities, providing a comprehensive understanding of drug delivery systems, experimental design, and data analysis. It is ideally suited for upper-undergraduate and graduate courses.In addition to the foundational material, the textbook delves into cutting-edge topics such as biomimetic drug delivery systems, targeted delivery systems, stimuli-responsive systems, and micro/nano-robots-ba... drug delivery systems. Emerging fields like cell therapy, artificial intelligence (AI) in drug delivery, and 3D printing-based systems are also explored. Professionals in the Pharma industry will benefit from the innovative concepts and platforms presented, making it a valuable addition to their resources.

    • Oral Delivery of Insulin

      • 2nd Edition
      • September 25, 2025
      • T.A. Sonia + 1 more
      • English
      • Hardback
        9 7 8 0 4 4 3 3 0 2 7 2 5
      • eBook
        9 7 8 0 4 4 3 3 0 2 7 3 2
      Oral delivery of Insulin, Second Edition is a complete reference on non-invasive insulin delivery systems, focusing on the prospect of oral delivery of peptides. The chapters in the revised edition present a comprehensive evaluation of the insulin therapy approaches, with an emphasis on insulin delivery strategies and current advances in engineered insulin delivery systems such as nano/microcarriers and hydrogels. Chapters provides an overview of diabetes mellitus, cover technological innovations, explore artificial intelligence and machine learning approaches to manage diabetes, explore a wide range of non-invasive and alternative routes of insulin administration, and much more.Other chapters cover challenges and strategies in oral insulin delivery, the experimental techniques used to develop oral insulin carriers, the use of polymeric nano and microparticles for insulin delivery, and the use of lipids and inorganic nanoparticles in insulin delivery. The final chapter provide an overview of current clinical trials on insulin delivery and future perspectives in the area. Clinicians can benefit from this information to develop a clear understanding about the research carried out worldwide in the field of oral delivery of insulin, including those in the clinical phase.

Related subjects

Drug delivery

Drug design

Drug dispensing

Drug manufacturing and packaging

Drug metabolism disposition

Pharmaceutical analysis

Pharmaceutical biotechnology

Pharmaceutical quality control

Pharmaceutical science general

Pharmaceutical technology

Pharmacoeconomics

Pharmacoepidemiology

Pharmacotherapy

Pharmacy

Pharmacy management